BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Xu W, Zhai T, You J, Chen Y. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. Acta Pharm Sin B 2019;9:745-57. [PMID: 31384535 DOI: 10.1016/j.apsb.2019.02.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Chen Y, Cheng NT, Yang ZT, Tang HX, Xu M. MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7. Immunol Invest 2021;:1-16. [PMID: 34251977 DOI: 10.1080/08820139.2021.1951753] [Reference Citation Analysis]
2 MacDonald-Ramos K, Michán L, Martínez-Ibarra A, Cerbón M. Silymarin is an ally against insulin resistance: A review. Ann Hepatol 2021;23:100255. [PMID: 32950646 DOI: 10.1016/j.aohep.2020.08.072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lei SS, Zhang NY, Zhou FC, He X, Wang HY, Li LZ, Zheng X, Dong YJ, Luo R, Li B, Jin HY, Yu QX, Lv GY, Chen SH. Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice. Evid Based Complement Alternat Med 2021;2021:6689727. [PMID: 34122607 DOI: 10.1155/2021/6689727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang K, Tan W, Liu X, Deng L, Huang L, Wang X, Gao X. New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. Biomed Pharmacother 2021;137:111326. [PMID: 33556870 DOI: 10.1016/j.biopha.2021.111326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dockalova H, Baholet D, Batik A, Zeman L, Horky P. Effect of Milk Thistle (Silybum marianum) Seed Cakes by Horses Subjected to Physical Exertion. Journal of Equine Veterinary Science 2022. [DOI: 10.1016/j.jevs.2022.103937] [Reference Citation Analysis]
6 Wang F, Chen S, Ren L, Wang Y, Li Z, Song T, Zhang H, Yang Q. The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice. Front Pharmacol 2020;11:55. [PMID: 32184719 DOI: 10.3389/fphar.2020.00055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fang Y, Yang H, Hu G, Lu J, Zhou J, Gao N, Gu Y, Zhang C, Qiu J, Guo Y, Zhang Y, Wen Q, Qiao H. The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03282-1] [Reference Citation Analysis]
8 Yu Y, He C, Tan S, Huang M, Guo Y, Li M, Zhang Q, Amantini C. MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα. Analytical Cellular Pathology 2021;2021:1-13. [DOI: 10.1155/2021/4853355] [Reference Citation Analysis]
9 Popescu RG, Bulgaru C, Untea A, Vlassa M, Filip M, Hermenean A, Marin D, Țăranu I, Georgescu SE, Dinischiotu A. The Effectiveness of Dietary Byproduct Antioxidants on Induced CYP Genes Expression and Histological Alteration in Piglets Liver and Kidney Fed with Aflatoxin B1 and Ochratoxin A. Toxins (Basel) 2021;13:148. [PMID: 33671978 DOI: 10.3390/toxins13020148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sayed AM, Hassanein EH, Salem SH, Hussein OE, Mahmoud AM. Flavonoids-mediated SIRT1 signaling activation in hepatic disorders. Life Sciences 2020;259:118173. [DOI: 10.1016/j.lfs.2020.118173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
11 Overi D, Carpino G, Franchitto A, Onori P, Gaudio E. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis. Cells 2020;9:E590. [PMID: 32131439 DOI: 10.3390/cells9030590] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
12 Hashimoto N, Han KH, Wakagi M, Ishikawa-Takano Y, Ippoushi K, Fukushima M. Bile acids induced hepatic lipid accumulation in mice by inhibiting mRNA expression of patatin-like phospholipase domain containing 3 and microsomal triglyceride transfer protein. Nutr Res 2021;92:12-20. [PMID: 34174520 DOI: 10.1016/j.nutres.2021.05.006] [Reference Citation Analysis]
13 Yan J, Nie Y, Liu Y, Li J, Wu L, Chen Z, He B. Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota. Front Cell Infect Microbiol 2022;12:824597. [DOI: 10.3389/fcimb.2022.824597] [Reference Citation Analysis]
14 Ali SA, Saifi MA, Godugu C, Talla V. Silibinin alleviates silica-induced pulmonary fibrosis: Potential role in modulating inflammation and epithelial-mesenchymal transition. Phytother Res 2021. [PMID: 34250649 DOI: 10.1002/ptr.7210] [Reference Citation Analysis]
15 Zhao YW, Yang J, Niu J, Wang T, Liang XD, Ren Y, Wang R. Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation. Evid Based Complement Alternat Med 2021;2021:3364579. [PMID: 34887931 DOI: 10.1155/2021/3364579] [Reference Citation Analysis]
16 Guo S, Bai X, Liu Y, Shi S, Wang X, Zhan Y, Kang X, Chen Y, An H. Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma. Front Pharmacol 2021;12:643489. [PMID: 33935737 DOI: 10.3389/fphar.2021.643489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Betsou A, Lambropoulou M, Georgakopoulou AE, Kostomitsopoulos N, Konstandi O, Anagnostopoulos K, Tsalikidis C, Simopoulos CE, Valsami G, Tsaroucha AK. The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR. J Pharm Pharmacol 2021:rgab062. [PMID: 33847359 DOI: 10.1093/jpp/rgab062] [Reference Citation Analysis]
18 Ji L, Cai X, Bai Y, Li T. Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China. Int J Gen Med 2021;14:2909-22. [PMID: 34234521 DOI: 10.2147/IJGM.S319759] [Reference Citation Analysis]
19 Wang RR, Zhang LF, Chen LP, Wang JY, Zhang L, Xu YS, Yang PL, Ji G, Liu BC. Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2021;2021:2234695. [PMID: 34966475 DOI: 10.1155/2021/2234695] [Reference Citation Analysis]
20 Song H, Chen Q, Xie S, Huang J, Kang G. GDF-15 prevents lipopolysaccharide-mediated acute lung injury via upregulating SIRT1. Biochemical and Biophysical Research Communications 2020;526:439-46. [DOI: 10.1016/j.bbrc.2020.03.103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
21 Yang L, Wang D, Zhang Z, Jiang Y, Liu Y. Isoliquiritigenin alleviates diabetic symptoms via activating AMPK and inhibiting mTORC1 signaling in diet-induced diabetic mice Treating type 2 diabetes with isoliquiritigenin. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.153950] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sun M, Zhao H, Jin Z, Lei W, Deng C, Yang W, Lu C, Hou Y, Zhang Y, Tang R, Zhao L, Zhang S, Yang Y. Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.05.018] [Reference Citation Analysis]
23 Xiaohong W, Jun Z, Hongmei G, Fan Q. CFLAR is a critical regulator of cerebral ischaemia-reperfusion injury through regulating inflammation and endoplasmic reticulum (ER) stress. Biomedicine & Pharmacotherapy 2019;117:109155. [DOI: 10.1016/j.biopha.2019.109155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 Cui S, Pan XJ, Ge CL, Guo YT, Zhang PF, Yan TT, Zhou JY, He QX, Cheng LH, Wang GJ, Hao HP, Wang H. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. Chin J Nat Med 2021;19:401-11. [PMID: 34092291 DOI: 10.1016/S1875-5364(21)60039-0] [Reference Citation Analysis]
25 Wang YL, Wu J, Li RX, Sun YT, Ma YJ, Zhao CY, Zou J, Zhang YY, Sun XD. A double-edged sword: The Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease. Curr Opin Pharmacol 2021;60:281-90. [PMID: 34500407 DOI: 10.1016/j.coph.2021.07.021] [Reference Citation Analysis]
26 Wang A, Li M, Huang H, Xiao Z, Shen J, Zhao Y, Yin J, Kaboli PJ, Cao J, Cho CH, Wang Y, Li J, Wu X. A review of Penthorum chinense Pursh for hepatoprotection: Traditional use, phytochemistry, pharmacology, toxicology and clinical trials. Journal of Ethnopharmacology 2020;251:112569. [DOI: 10.1016/j.jep.2020.112569] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
27 Wang Z, Yan J, Yang F, Wang D, Lu Y, Liu L. MicroRNA-326 prevents sepsis-induced acute lung injury via targeting TLR4. Free Radical Research 2020;54:408-18. [DOI: 10.1080/10715762.2020.1781847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
28 Zhang Y, Wen J, Liu D, Qiu Z, Zhu Q, Li R, Zhang Y. Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice. Life Sci 2021;281:119778. [PMID: 34192596 DOI: 10.1016/j.lfs.2021.119778] [Reference Citation Analysis]
29 Yu LY, Li WY, Lin J. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver mice. Shijie Huaren Xiaohua Zazhi 2020; 28(4): 113-121 [DOI: 10.11569/wcjd.v28.i4.113] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sci 2021;271:119220. [PMID: 33592199 DOI: 10.1016/j.lfs.2021.119220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Jiang WL, Zhao KC, Yuan W, Zhou F, Song HY, Liu GL, Huang J, Zou JJ, Zhao B, Xie SP. MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via Inactivating Cab39/AMPKα Pathway. Oxid Med Cell Longev 2020;2020:8822361. [PMID: 33101593 DOI: 10.1155/2020/8822361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Ye J, Zheng J, Tian X, Xu B, Yuan F, Wang B, Yang Z, Huang F. Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway. Marine Drugs 2022;20:225. [DOI: 10.3390/md20040225] [Reference Citation Analysis]
33 Li L, Xia Y, Ji X, Wang H, Zhang Z, Lu P, Ding Q, Wang D, Liu M. MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance. Exp Cell Res 2021;407:112801. [PMID: 34461107 DOI: 10.1016/j.yexcr.2021.112801] [Reference Citation Analysis]
34 Goh ZH, Tee JK, Ho HK. An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage. Int J Mol Sci 2020;21:E3714. [PMID: 32466226 DOI: 10.3390/ijms21103714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, Wang N, Feng Y. Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. Front Pharmacol 2020;11:601. [PMID: 32477116 DOI: 10.3389/fphar.2020.00601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
36 Zhang Z, Wen H, Peng B, Weng J, Zeng F. CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis. FASEB J 2021;35:e21230. [PMID: 33769609 DOI: 10.1096/fj.202000683R] [Reference Citation Analysis]
37 Wang C, Li YH, Yang ZT, Cheng NT, Tang HX, Xu M. The function and mechanism of microRNA-92a-3p in lipopolysaccharide-induced acute lung injury. Immunopharmacol Immunotoxicol 2021;:1-11. [PMID: 34783628 DOI: 10.1080/08923973.2021.2001497] [Reference Citation Analysis]
38 Li J, Deng X, Bai T, Wang S, Jiang Q, Xu K. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice. Int Immunopharmacol 2020;88:106961. [PMID: 33182038 DOI: 10.1016/j.intimp.2020.106961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Chen M, Xie Y, Gong S, Wang Y, Yu H, Zhou T, Huang F, Guo X, Zhang H, Huang R, Han Z, Xing Y, Liu Q, Tong G, Zhou H. Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. Pharmacol Res 2021;172:105849. [PMID: 34450307 DOI: 10.1016/j.phrs.2021.105849] [Reference Citation Analysis]
40 Shi X, Li Z, Cai W, Liu Y, Li S, Ai M, Sun J, Hou B, Ni L, Qiu L. Chemical Constituents from Albiziae Cortex and Their Ability to Ameliorate Steatosis and Promote Proliferation and Anti-Oxidation In Vitro. Molecules 2019;24:E4041. [PMID: 31703459 DOI: 10.3390/molecules24224041] [Reference Citation Analysis]
41 Fu Z, Jiao Y, Wang J, Zhang Y, Shen M, Reiter RJ, Xi Q, Chen Y. Cardioprotective Role of Melatonin in Acute Myocardial Infarction. Front Physiol 2020;11:366. [PMID: 32411013 DOI: 10.3389/fphys.2020.00366] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
42 Cicuéndez B, Ruiz-Garrido I, Mora A, Sabio G. Stress kinases in the development of liver steatosis and hepatocellular carcinoma. Mol Metab 2021;50:101190. [PMID: 33588102 DOI: 10.1016/j.molmet.2021.101190] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Zhai T, Xu W, Liu Y, Qian K, Xiong Y, Chen Y. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. Oxid Med Cell Longev 2020;2020:2313641. [PMID: 33354276 DOI: 10.1155/2020/2313641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Rein-Fischboeck L, Haberl EM, Bajraktari G, Feder S, Pohl R, Eggenhofer E, Buechler C. Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver. Exp Mol Pathol 2020;113:104363. [PMID: 31881201 DOI: 10.1016/j.yexmp.2019.104363] [Reference Citation Analysis]
45 Shi Z, Li T, Liu Y, Cai T, Yao W, Jiang J, He Y, Shan L. Hepatoprotective and Anti-Oxidative Effects of Total Flavonoids From Qu Zhi Qiao (Fruit of Citrus Paradisi cv.Changshanhuyou) on Nonalcoholic Steatohepatitis In Vivo and In Vitro Through Nrf2-ARE Signaling Pathway. Front Pharmacol 2020;11:483. [PMID: 32390839 DOI: 10.3389/fphar.2020.00483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
46 Lu Y, Shao M, Xiang H, Zheng P, Wu T, Ji G. Integrative transcriptomics and metabolomics explore the mechanism of kaempferol on improving nonalcoholic steatohepatitis. Food Funct 2020;11:10058-69. [PMID: 33135718 DOI: 10.1039/d0fo02123g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
47 Yu Y, Tian T, Tan S, Wu P, Guo Y, Li M, Huang M. MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice. Bioengineered 2022;13:2927-42. [PMID: 35038955 DOI: 10.1080/21655979.2021.2017698] [Reference Citation Analysis]
48 Vandewege MW, Sotero-Caio CG, Phillips CD. Positive Selection and Gene Expression Analyses from Salivary Glands Reveal Discrete Adaptations within the Ecologically Diverse Bat Family Phyllostomidae. Genome Biol Evol 2020;12:1419-28. [PMID: 32697843 DOI: 10.1093/gbe/evaa151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tamer F, Ulug E, Akyol A, Nergiz-unal R. The potential efficacy of dietary fatty acids and fructose induced inflammation and oxidative stress on the insulin signaling and fat accumulation in mice. Food and Chemical Toxicology 2020;135:110914. [DOI: 10.1016/j.fct.2019.110914] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]